Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS)

Sleep and Breathing

Volumn 12, Issue 2, 2008, Pages 149-154

  Ozkan, Yeşim ^a   Fırat, Hikmet ^b   Şimşek, Bolkan ^a   Torun, Meral ^a   Yardim Akaydin, Sevgi ^a  

^a GAZI UNIVERSITY   (Turkey)

^b Dişkapi Education and Research Hospital ^*  (Turkey)

Author keywords

ADMA; Apnea; Homocysteine; Nitric oxide; Oxidative status; Sleep apnea

Indexed keywords

HOMOCYSTEINE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUSAL ATTRIBUTION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENZYME BLOOD LEVEL; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; OXIDATION; OXIDATIVE STRESS; PATIENT MONITORING; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE;

EID: 41749091605     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-007-0148-4     Document Type: Article

References (45)

1. Baldwin CM, Bootzin RR, Schwenke DC, Quan SF (2005) Antioxidant nutrient intake and supplements as potential moderators of cognitive decline and cardiovascular disease in obstructive sleep apnea. Sleep Med Rev 9:459-476
2. Jordan AS, McEvoy RD (2003) Gender differences in sleep apnea: epidemiology, clinical presentation and pathogenic mechanisms. Sleep Med Rev 7:377-389
3. Barcelo A, Barbe F, de la Pena M, Vila M, Perez G, Pierola J, Duran J, Agusti AGN (2006) Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27:756-760
4. Christou K, Markoulis N, Moulas AN, Pastaka C, Gourgoulianis KI (2003) Reactive oxygen metabolites (ROS) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 7:105-109
5. Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27:123-128
6. Gautier-Sauvigné S, Colas D, Parmantier P, Clement P, Gharib A, Sarda N, Cespuglio R (2005) Nitric oxide and sleep. Sleep Med Rev 9:101-113
7. Lavie L (2003) Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 7:35-51
8. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142
9. Haight JSJ, Djupesland PG (2003) Nitric oxide (NO) and obstructive sleep apnea (OSA). Sleep Breath 7:53-61
10. Ip MSM, Lam B, Chan LY, Zheng L, Tsang KWT, Fung PCW, Fung PCW, Lam WK (2000) Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Repir Crit Care Med 162:2166-2171
11. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, Santa T, Imai K, Hashimoto M, Yoshizumi M, Ouchi Y (2005) Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure - possible involvement of nitric oxide and asymmetric NG,NG-dimethylarginine. Cir J 69:221-226
12. Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lucke C, Mayer K, Olschewski H, Seeger W, Grimminger F (2000) Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: Response to CPAP therapy. Thorax 55:1046-1051
13. Leiper JM, Vallance P (2006) The synthesis and metabolism of asymmetric dimethylarginine (ADMA). Eur J Clin Pharmacol 62:33-38
14. Guldener CV, Stehouwer CDA (2000) Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost 26:281-289
15. Weiss N (2005) Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 6:27-36
16. 2 mediation. Arterioscler Thromb Vasc Biol 21:233-237
17. Dayal S, Lentz SR (2005) ADMA and hyperhomocysteinemia. Vasc Med 10:S27-33
18. Stühlinger MC, Stanger O (2005) Asymetric dimethyl-L-arginine (ADMA): A possible link between homocyst(e)ine and endothelial dysfunction. Curr Drug Matab 6:3-14
19. Rechtschaffen A, Kales A (1968) A Manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. NIH publication no. 204. National Institute of Neurological Disease and Blindness, Bethesda, MA
20. Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62-71
21. Chen BM, Xia LW, Zhao RQ (1997) Determination of NG, NG-dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatogr B 692:467-471
22. Verde V, Fogliano V, Ritieni A, Maiani G, Morisco F, Caporaso N (2002) Use of N,N-dimethyl-p-phenylenediamine to evaluate the oxidative status of human plasma. Free Radic Res 36:869-873
23. Krijt J, Vackova M, Kozich V (2001) Measurement of homocysteine and other aminothiols in plasma: Advantages of using tris(2-carboxyethyl)phosphine as reductant compared with tri-n-buthylphosphine. Clin Chem 47:1821-1828
24. Vester B, Rasmussen K (1991) High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 29:549-554
25. Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnoea syndrome as a risk factor for hypertention: Population study. BMJ 320:479-482
26. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, O'Connor GT, Boland LL, Schwartz JE, Samet JM (2001) Sleep-disordered breathing and cardiovascular disease: Croos-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19-25
27. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD (1999) Risk factors for central and obstructive apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160:1101-1106
28. Von Kanel R, Le DT, Nelesen RA, Mills PJ, Ancoli-Israel S, Dimsdale JE (2001) The hypercoagulable state in sleep apnea is related to comorbid hypertention. J Hypertens 19:1445-1451
29. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Am J Respir Crit Care Med 162:566-570
30. Çiftçi TU, Kokturk O, Bukan N, Bilgihan A (2004) The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28:87-91
31. Carlson JT, Rangemark C, Hedner JA (1996) Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 14:577-584
32. Hernández C, Abreu J, Abreu P, Colino R, Jimenéz A (2006) Effects of nasal positive airway pressure treatment on oxidative stress in patients with sleep apnea-hypopnea syndrome. Arch Bronconeumol 42:125-129
33. Jordan W, Cohrs S, Degner D, Meier A, Rodenbeck A, Mayer G, Pilz J, Rüther E, Kornhuber J, Bleich S (2006) Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm 113:239-254
34. Doshi S, McDowell I, Goodfellow J, Stabler S, Boger R, Allen R, Newcombe R, Lewis M (2005) Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia. Metabolism 54:351-360
35. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG (1999) Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 100:1161-1168
36. Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH, Tripepi G, Sesti G, Zoccali C (2005) Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 46:518-523
37. Özkan Y, Özkan E, Şimşek B (2002) Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol 82:269-277
38. Valkonen VP, Paiva H, Salonen JT, Lakka TA, Lehtimaki T, Laakso J, Laaksonen R (2001) Risk of acute coronary events and serum concentration of asymmetric dimethylarginine. Lancet 358:2127-2128
39. Lavie L, Perelman A, Lavie P (2001) Plasma homocysteine levels in obstructive sleep apnea. Association with cardiovascular morbidity. Chest 120:900-908
40. Jordan W, Berger C, Cohrs S, Rodenbeck A, Mayer G, Niedmann PD, von Ahsen N, Rüther E, Kornhuber J, Bleich S (2004) CPAP-therapy effectively lowers serum homocysteine in obstrüctive sleep apnea syndrome. J Neural Transm 111:683-689
41. Kokturk O, Ulukavak-Ciftci T, Mollarecep E, Ciftci B (2006) Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome. Respir Med 100:536-541
42. Cheng CH, Huang MC, Liu SC, Lin KL, Huang YC (2006) Traditional cardiovascular risk factors but not homocysteine are associated with obstructive sleep apnea. Nutr Res 26:59-64
43. Robinson GV, Pepperell JCT, Segal HC, Davies RJO, Stradling JR (2004) Circulating cardiovascular risk factors in obstructive sleep apnea: Data from randomized controlled trials. Thorax 59:777-782
44. Yildirim AO, Bulau P, Zakrzewicz D, Kitowska KE, Weissmann N, Grimminger F, Morty RE, Eickelberg O (2006) Increased protein arginine methylation in chronic hypoxia: Role of protein arginine methyltransferases. Am J Respir Cell Mol Biol 35:436-443
45. Tyagi N, Sedoris KC, Steed M, Ovechkin AV, Moshal KS, Tyagi SC (2005) Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 289:H2649-2656